Thus, short-term therapeutic inhibition of the nucleocytoplasmic transport gene, Xpo1, induces tumor regression without affecting normal adjacent liver in an autochthonous transgenic mouse model of MYC-induced HCC. This evidence concerns the gene XPO1 and hepatocellular carcinoma.